Isolated @entity4816 (IRV) is a form of @entity4816 without other @entity32 or systemic @entity1333 . Treatment of IRV is a difficult problem. We report the results of treatment of 43 IRV @entity1 (25 @entity1 and 18 @entity1 , mean age 32.5 +/- 5.5 years with a range of 22-42 years). The main therapy for IRV were corticosteroids. They were used by pulse therapy, orally and locally (periocular injections). Improvement of visual acuity was more pronounced in @entity1 treated by pulse therapy (0.35 +/- 0.15) than in those treated orally (0.16 +/- 0.06, p = 0.0132) and parabulbarly (0.06 +/- 0.12, p = 0.0009). Resorption of retinal perivascular exudate was sooner achieved by @entity134 pulse therapy than by oral treatment (8.1 +/- 2.2 days vs. 17.9 +/- 2.8 days, p < 0.0000) or periocular injection of @entity230 (30.9 +/- 7.1 days, p < 0.0000). @entity617 (10-20 mg) was prescribed for 4-12 months in order to prevent IRV recurrences. @entity134 -resistant @entity1 were treated with @entity205 (5 mg/kg). The treatment was supplemented by fibrinolytics, angioprotectors, and antioxidants.

[Conservative therapy of isolated XXXX ].

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'men'] @entity32 :: ('MESH:D007249', 'Disease') :: ['types of eye inflammation'] @entity617 :: ('MESH:D011239', 'Chemical') :: ['Prednisolone'] @entity1333 :: ('MESH:D014657', 'Disease') :: ['vasculitis'] @entity134 :: ('CHEBI:35341', 'Chemical') :: ['Steroid', 'steroid'] @entity205 :: ('MESH:D016572', 'Chemical') :: ['cyclosporin A'] @entity230 :: ('MESH:D013256', 'Chemical') :: ['steroids'] @entity4816 :: ('MESH:D031300', 'Disease') :: ['retinal vasculitis']
@entity4816 :: (MESH:D031300,Disease) :: ['retinal vasculitis']
